Anthropic misses self-imposed safety deadline for provable-inference prototype
Anthropic’s September 30 deadline for Phase 1 of its provable-inference prototype has passed without public confirmation of completion. The milestone, originally set for May 15, was delayed to focus on broader security efforts. Phase 1 only covers foundational components and cost analysis—not a deployable system—yet its delay underscores tensions between rapid AI development and safety…
Key points
- Anthropic’s September 30 deadline for Phase 1 of provable-inference prototype passed without confirmation
- Phase 1 only includes component inventory and cost analysis, not a deployable system
- Claude now drives 26% of Anthropic’s R&D, with Opus 5.5 cutting costs by 40%
The company has avoided discussing the delay, despite its significance for its planned $2 trillion IPO. Meanwhile, Anthropic has prioritized product releases: Claude now powers 26% of its R&D, Claude Opus 5.5 cut workload costs by 40%, and a biology lab used 950 Claude agents to discover a CRISPR-like enzyme system in 21 hours.
Model page: Claude Opus 5.5 →
Anthropic’s Self-Imposed Safety Deadline Arrives in Two Days. The Silence Is the Signal.
finance.yahoo.com · 28 September 2026
Loading the full article…
This text was published by finance.yahoo.com and written by Lena Park. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Research
All →- PyTorch tutorial shows how to cut drone data usage by 94% · 1 src
- Article outlines five practices for building robust Python AI libraries · 1 src
- Vector databases explain how AI retrieves similar data at scale · 1 src
- PhAI Labs introduces JEPA-Anything framework for cross-domain world models · 2 src
- Researchers introduce VIMA for finding disease patterns in tissue data · 2 src
Comments
via GitHub Discussions